A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

NCT07392372 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV -1 Infection

Interventions

DRUG: BNT351
DRUG: Placebo
DRUG: BNT351
DRUG: Placebo

Sponsor

BioNTech SE